Buelga et al. 2005

Population Pharmacokinetic Analysis of Vancomycin in Patients with Hematological Malignancies

Antimicrobial Agents and Chemotherapy · 10.1128/AAC.49.12.4934-4941.2005

Structure

A one-compartment model, driven by weight and creatinine clearance.

Study population

Hematologic malignancy patients — Spain and Europe. Fitted to 215 patients and 1,004 concentration observations.

Covariate As reported
Age 51.5 ± 15.9 yr
Weight 64.7 ± 11.3 kg
CrCl 89.4 ± 39.2 mL/min
SCr 0.9 ± 0.4 mg/dL

Reported as the source publication gives them — mean ± SD, or median with range or interquartile range.

Equations

The model's structural parameters as Chorus implements them.

CL=1.08CrCl601000CL = 1.08 \cdot CrCl \cdot \frac{60}{1000}V1=0.98WeightV_1 = 0.98 \cdot Weight
LaTeX source
CL = 1.08 \cdot CrCl \cdot \frac{60}{1000}
V_1 = 0.98 \cdot Weight

Implementation notes

Hematological-malignancy cohort with high vancomycin clearance. CL scales with Cockcroft-Gault CrCl (conventional SCr, total body weight); V with total body weight.

Simulation settings

Models

selected

Dose candidates (mg)

Interval candidates (h)

Demographics

Physical characteristics.

kg
cm
yr